Cellectis S.A. current report, Q1 FY2023

Cellectis S.A. Form 6-K Summary

Business Context and Reporting Period

This Form 6-K was filed by Cellectis S.A., a foreign private issuer headquartered in Paris, France, on January 4, 2023. The filing covers the month of January 2023 and serves to distribute a press release dated January 4, 2023 (Exhibit 99.1).

Financial Metrics

The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. The document is a cover sheet referencing a press release and does not contain a financial statement or detailed operational data.

Material Changes

No material changes versus a prior comparable period are detailed in the provided text. The filing serves solely to transmit the referenced press release.

Guidance, Outlook, and Risks

The filing text does not contain management commentary, guidance, outlook, risks, contingencies, or unusual items. These details are presumed to be within the attached press release (Exhibit 99.1), which is not included in the input content.

Key Facts for Investor Verification

  • Verify the content of the press release dated January 4, 2023, referenced as Exhibit 99.1, as the filing itself contains no operational details.
  • Confirm the company's status as a foreign private issuer filing under Form 20-F.
  • Note that the Chief Executive Officer, André Choulika, signed the report on behalf of the registrant.